Background
Oral squamous cell carcinoma (OSCC) is an invasive malignant tumor with different degrees of differentiation. The poor-differentiated OSCC has a tendency to metastasize to early lymph nodes [
1]. It accounts for about 3% of the world’s malignant tumors [
2]. Every year, 1.6 million people are diagnosed and 333,000 people die from head and neck squamous cell carcinoma (HNSCC), of which half the cases are OSCC [
3]. Moreover, incidence rates of OSCC in developing countries are higher than developed countries [
2]. The latest academic statistics shows that the five-year survival rate of patients with OSCC is about 60% [
4], while the 5-year survival rate of patients with advanced cancer is even lower. OSCC has become a progressively serious global problem.
Circular RNAs (circRNAs) are a class of noncoding RNA molecules that do not have a 5′-end cap or 3′-end poly (A) tail. Previous reports have shown that circular RNAs are endogenous, stable, abundant, and conserved RNA molecules that can have cell type- or developmental stage-specific expression patterns in eukaryotic cells [
5‐
7]. Studies have revealed the presence of differentially expressed circular RNA in various tumor tissues, which are significantly associated with distant metastases, TNM staging, and other clinical features [
8,
9]. Including colon, gastric, and esophageal cancers [
10,
11]. Studying features of circRNAs can provide new insights into tumor pathogenesis. However, literature on the expression of circular RNA in oral squamous cell carcinoma is limited.
To investigate the regulatory role of circRNAs in OSCC, high-throughput sequencing was used to screen differentially expressed circular RNA in paired OSCC tissues and adjacent normal tissue samples [
12]. We found that hsa_circ_0005379 is an OSCC tumor suppressor gene associated with tumor size and differentiation. Upregalation of hsa_circ_0005379 effectively inhibits migration, invasion, proliferation of OSCC cells and angiogenesis formation in vitro, and suppresses OSCC growth in nude mice in vivo. We also found that hsa_circ_0005379 may be involved in the regulation of the epidermal growth factor receptor (EGFR) pathway by affecting EGFR expression. Moreover, our study showed that high expression of hsa_circ_0005379 combined with cetuximab can significantly promote OSCC cell apoptosis. Taken together, our findings provide evidence that hsa_circ_0005379 regulates cancer and may be a new therapeutic target for OSCC treatment.
Methods
Patients and tissue samples
All patient tissue samples were obtained from the Stomatological Center of Peking University Shenzhen Hospital (Shenzhen, China), between 2016 and 2018. Patients enrolled in the study was selected to rule out systemic disease and preoperative radiotherapy or chemotherapy. The histopathological grading of tumors was performed according to the 2018 World Health Organization classification criteria for head and neck cancer. The circular RNA profiling was obtained through high-throughput sequencing of four pairs of specimens. (Guangzhou Gene Denovo Biotechnology Co. Ltd., Guangzhou, China). This study was approved by the Ethics Committee of Peking University Health Science Center (IRB00001053–08043).
Cell culture and transfection
Human OSCC cell lines SCC9, SCC15, SCC25, and CAL27 are gifts given by Wuhan University (Wuhan, China). Human oral keratinocyte (HOK) cells were obtained from the cell bank of the Chinese Academy of Sciences (Shanghai, China). All cells were cultured in Dulbecco’s modified Eagle medium (DMEM; Gibco, New York, USA). Human umbilical vein endothelial cells (HUVEC) and culture medium were bought from Procell Life Science and Technology Company (WuHan, China). All cell lines were cultured at 37 °C incubator with 5% CO2. The siRNAs for hsa_circ_0005379 were synthesized by RiboBio Co. Ltd. (Guangzhou, China). The siRNA sequences are as follows:
siRNA-1: 5′-CAAGGAAUGUAUCCUGUCA-3′;
siRNA-2: 5′-AAGGAUUUGCAAGGAAUGUAU-3′;
siRNA-3: 5′-GAUUUGCAAGGAAUGUAUCCU-3′.
Lipofectamine 3000 (Gibco, New York, USA) was used for siRNA transfection. All three siRNAs gave identical results.
Lentivirus infection and monoclonal cell screening
The lentiviral plasmid containing GFP and puromycin-resistant gene was constructed by HanBio Co. Ltd. (Shanghai, China). Polybrene/medium mixture with packaged lentivirus was incubated with SCC25 and CAL27 cells for 48 h. After infection, the transduced cells were screened by puromycin (SCC25, 6 μg/ml; CAL27, 10 μg/ml; Qcbio Science & Technologies Co. Ltd. Shanghai, China). The screened cells were diluted and plated into 96-well plates to get a single cell per well. Monoclonal cells were verified by qRT-PCR. Fluorescence microscopy was used to observe the expression of GFP in infected cells.
RNA preparation and qRT-PCR
Total RNA was extracted with an RNeasy Mini Kit (QIAGEN, Hilden, Germany). RNA was incubated with 3 U/mg RNase R (Epicenter) for 15 min at 37 °C. For reverse transcription, 500 ng of RNase R-treated RNA was reverse transcribed using Prime Script RT Master Mix (Takara Bio Inc., Kusatsu, Japan). PCR reactions were performed using PCR Master Mix (2×) (Thermo Fisher Scientific, Waltham, MA, USA). Primers used for qRT-PCR are listed as follows:
hsa_circ_0005379-F1: GCCCATACCTTTATCCACTC
hsa_circ_0005379-R1: GTCAACATTCCAGTCTCTTCCT
hsa_circ_0005379-F2: CCTAAGAAGACCACAATGCG
hsa_circ_0005379-R2:CCTCCGTAGTAAGGGTTTCG
β-actin-F: AAACTGGAACGGTGAAGGTG
β-actin-R: AGTGGGGTGGCTTTTAGGAT.
CCK-8 assay
Tumor cells were seeded into 96-well plates at 2 × 103 cells per well. CCK-8 (Beyotime, Shanghai, China) was added at 10 μl/well at different time points and incubated for 1 h. The OD value at 450 nm absorbance was measured. To treat the cells with EGFR drugs, NSC228155 was added at the concentration of 29 μg/ml and incubated for 15 min. Cetuximab was added at the concentration of 10 μg/ml and incubated for 72 h.
5-ethynyl-2′-deoxyuridine (EdU) incorporation assay
Tumor cells were seeded at 4 × 103 cells/well into 96-well plates and grown to logarithmic phase. Then EdU dye, PBS buffer, Apollo and Hoechst 33342 (Beyotime Biotechnology, Shanghai, China) were used to stain the cells, respectively. Images were taken randomly under a fluorescence microscopy. The cells were counted using Image J software.
Co-cultivation experiment
The two types of OSCC cells conventionally stably transduced (tumor cells with high expression of hsa_circ_0005379) were cultured in 6-well plates in serum-free medium for 24 h. Supernatant medium was collected as conditioned medium. After trypsin digestion, HUVEC cells were centrifuged and the cells were resuspended in serum-free DMEM medium and counted. Then, 3 × 10 4 cells were added to each well and the medium was adjusted to 100 μl using serum-free medium. In the lower chamber, two kinds of conditioned medium or two kinds of stably transduced cells cultured with serum-free DMEM medium were added. After 24 h, the medium was discarded and the cells were fixed in 4% paraformaldehyde and stained with crystal violet staining solution. The cells above the membrane were observed and photographed on an inverted microscopy.
Matrigel was added to 24-well plates at a concentration of 200 μl/well and placed in an incubator for 1 h to solidify. The HUVECs were inoculated into the above 24-well plate, and the confluency is about 60% when the cells attached. The cells were cultured for 12 h by adding the above mentioned conditioned medium or OSCC cells overexpressing hsa_circ_0005379. The photographs were taken on an inverted microscopy.
Flow cytometry
Annexin V-FITC Apoptosis Assay Kit (Beyotime Biotechnology Co. Ltd., Shanghai, China) was used to measure the cell apoptosis rate. Tumor cells were seeded into 6-well plates and grown to logarithmic phase. The cells were harvest by digestion and resuspended in 100 μl of 1 × annexin-binding buffer. 5 μl of annexin V and 1 μl of propidium iodide (PI) reagent were added to each well and incubated for 15 min. After incubation, 400 μl of 1 × annexin-binding buffer was added to stop staining. The apoptosis rate was finally measured using FACSCalibur flow cytometer (BD Biosciences, New York, USA).
Hoechst 33258 staining experiment
Tumor cells were seeded at 4 × 105 cells/well into 24-well plates and grown to logarithmic phase. Cells were then fixed using 4% paraformaldehyde and stained by Hoechst 33258 (Beyotime Biotechnology Co. Ltd., Shanghai, China). The morphology and staining of tumor cells nuclei were observed under an inverted fluorescence microscopy.
Wound-healing assay
Cells were seeded in 6-well plates and cultured until confluent. Use a sterile 200 μl pipette to scratch the bottom of the 6-well plate. The exfoliated tumor cells were washed with PBS, and cell migration photographs were taken under a microscope at 0 h and 48 h, respectively.
Migration and invasion assays
Migration and invasion experiments were performed using a Transwell chamber with or without Matrigel (Corning Life Sciences, NY, USA). The upper chamber is serum-free DMEM, and the lower chamber is DMEM containing 10% FBS. After 24 and 48 h of culture, tumor cells which passed through the chamber were fixed and stained by 4% paraformaldehyde and 0.1% crystal violet. Images were taken under an inverted microscopy.
Western blot analysis
Cellular extracts were prepared at 4 °C in RIPA buffer (Beyotime Biotechnology, Shanghai, China). Western blot analysis was performed using commercial primary antibodies against the following proteins: Bcl-2 (1:2000; ab32124, Abcam), BAX (1:2000; ab32503, Abcam), MMP-9 (1:2000; ab38898, Abcam), cyclin D1 (1:2000; ab134175, Abcam), GAPDH (1:2000; ab8245, Abcam), vimentin (1:1000; 5741 T, CST), E-cadherin (1:1000; 3195 T, CST) N-cadherin (1:1000; 13,116 T, CST), β-catenin (1:1000; 8480 T, CST), EGFR (1:1000; 2085S, CST), CD31 (1:1000; 3528S, CST) and p-EGFR (1:1000; 3777S, CST). The bands were detected using HRP-conjugated secondary antibodies from Beyotime Biotechnology (Shanghai, China): goat anti-rabbit (1:1000, A0208) and goat anti-mouse (1:1000, A0216). Chemiluminescence was identified using Millipore chromogenic solution (MilliporeSigma, Burlington, MA, USA).
Tumorigenesis and staining
Transduced CAL27 cells (2 × 107 cells in 100 μl) were injected into 4-week-old Balb/c athymic nude mice (Siliake Jingda Experimental Animal Co. Ltd., Hunan, China).
The tumor volume of nude mice was measured and recorded according to V = πAB2/6 (V: tumor volume, A: the largest diameter, B: the perpendicular diameter). After 6 weeks, the nude mice were euthanized. Tumors of nude mice were dissected and tumor weights were measured. Tumor specimens were treated accordingly to perform hematoxylin and eosin (H&E) staining, Western blot, IHC staining.
Image processing and statistical analysis
All images shown are wide-field microscopy images. Results in graphs are shown as the mean ± SEM from three independent experiments. All statistical data were analyzed using SPSS 17.0 software (SPSS, Chicago, IL, USA). Two-tailed Student’s t-tests were used to determine P values; P < 0.05 was considered significant.
Discussion
OSCC is a common malignancy in the head and neck. About 540,000 new patients are diagnosed each year. Its high incidence rate poses a serious challenge to public health [
19,
20]. Early and well-differentiated OSCCs usually achieve good results through active surgical treatment. However, for the advanced and poorly differentiated OSCC, even treated by surgical treatment, radiation therapy or chemotherapy, the five-year survival rate of the patients is only about 60% [
21]. When the distant metastasis occurs, the patients’ survival and quality of life is even more difficult to guarantee [
22].
CircRNAs is a very peculiar product in the process of the transmission and function of life genetic information. The current research shows that circRNA is also subject to the central law. Due to the particularity of the structure, circRNA has a unique function different from traditional linear nucleic acid molecules [
23]. Functional circRNAs have been identified to act as microRNA sponges and RNA-binding protein (RBP) sequestering agents, as well as transcriptional regulators [
24]. These multiple functional roles indicate great potential for circRNAs in biological applications. A growing number of studies have shown that circRNAs play a regulatory role in the tumor progression [
9,
25‐
27].
Like other malignancies, the occurrence and development of OSCC is a series of complex biological cellular processes involved with coding and noncoding genes [
28]. Recently, the regulatory role of circRNAs in OSCC has also begun to attract attention. Chen et al. found that circRNA_100290 can bind miR-29 through endogenous competition, thereby eliminating miR-29 inhibition of CDK6 and promoting the proliferation of OSCC cells [
29]. Research on circRNAs in OSCC has just begun and further research in OSCC-specific circRNA expression is needed. In this study, high-throughput circRNA microarray technology was used to screen differentially expressed circRNA in four pairs of cancer tissues of OSCC patients. The series of cytological experiments confirmed that changing the expression level of hsa_circ_0005379 can affect the malignant biological behavior of OSCC cells. The western blot assay detected significant changes in proliferation and apoptosis. EMT plays an important role in the process of tumor invasion. We detected changes in E-Cadherin, β-Catenin, and other core indicators that are consistent with our invasion experiment results. The ability of angiogenesis is closely related to the occurrence and development of tumors. The stronger the angiogenic ability, the greater the possibility of tumor cell proliferation and distant metastasis. Our experiment found that after overexpressing hsa_circ_0005379, the ability of tumor cells to induce HUVECs to form blood vessels was significantly lower than that of the control group. Tumor angiogenesis can be evaluated from the levels of CD31, also known as platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31). The richer the CD31 content, the faster the tumor proliferation rate. Our experimental results showed that after overexpression of hsa_circ_0005379, the CD31 content in nude mice was significantly lower than that in the control group, indicating that the differential expression of hsa_circ_0005379 affected the angiogenesis of tumor cells.
By knocking down hsa_circ_0005379 in SCC25 and CAL27 cell lines using siRNA, we found that the level of proliferation-related apoptosis protein were changed. However, the results of cytological experiments such as CCK-8, wound healing assay, and Transwell assays were not significantly different, probably due to the low level of hsa_circ_0005379 in OSCC lines and the inherent high degree of malignancy of SCC25 and CAL27 cells.
EGFR is a tyrosine kinase type I receptor whose family members include four homologous receptors: EGFR (HER1), HER2, HER3, and HER4. Studies have shown a high or abnormal expression of EGFR in many solid tumors, indicating that EGFR is involved in the malignant biological behavior of tumor cells [
30,
31]. Upregulation of EGFR is closely related to early metastasis and poor prognosis. Over 90% of patients with head and neck squamous cell carcinoma test positive for EGFR [
32]. In this experiment, the expression level of EGFR protein in OSCC cell lines SCC25 and CAL27 was significantly changed by overexpression or knockdown of hsa_circ_0005379, indicating that hsa_circ_0005379 can regulate the EGFR pathway. Using EGFR pathway agonists and inhibitors to alter the expression levels of phosphorylated EGFR in the cells, we found only weak expression changes of hsa_circ_0005379 that were not statistically significant. This indicates that hsa_circ_0005379 may be located upstream of the EGFR pathway and regulate EGFR expression levels. Based on the high expression of EGFR in OSCC, a series of targeted therapeutics for EGFR have been developed [
33,
34].
Cetuximab is a recombinant human murine chimeric IgG1 monoclonal antibody, which has high affinity for EGFR, inhibits cell cycle progression, and induces tumor cell apoptosis by specifically binding to the extracellular EGFR domain. This reduces the production of MMPs and vascular endothelial growth factors, and inhibits tumor invasion and metastasis. Cetuximab has shown good clinical efficacy and tolerability for EGFR expression in head and neck cancers [
35,
36]. This study found that changes in early apoptotic rates is not obvious in cells after high hsa_circ_0005379 expression in SCC25 and CAL27 cell lines. However, when cetuximab was added after overexpressing hsa_circ_0005379 in SCC25 and CAL27 cells, the early apoptotic rate of the cells significantly increased to 38.35 and 35.77%, respectively. This indicates that high hsa_circ_0005379 expression increases cetuximab sensitivity and provides a new potential target for OSCC anticancer drugs design in the future.
Using software, we also identified possible miRNA targets of hsa_circ_0005379, including hsa-miR-145, hsa-miR-182. However, the mechanisms still need to be investigated in subsequent experiments. To date, only a few functional circRNAs have been reported in OSCC. Therefore, more effort is needed to elucidate the functions and key mechanisms of OSCC-specific circRNAs, so that circRNAs can be used effectively in translational and precision medicine.